HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic markers and inflammatory bowel disease: immunoglobulin allotypes (GM, KM) and protease inhibitor.

Abstract
We have studied immunoglobulin allotypes (GM and KM) in 101 patients with Crohn's disease, 51 patients with ulcerative colitis, and 99 healthy local blood donor controls. In addition, protease inhibitor (PI) types were examined in a random subset of patients and in all controls. No significant differences were found between Crohn's disease patients and controls, or between ulcerative colitis patients and controls, in the frequencies of GM phenotypes, GM haplotypes, KM phenotypes, or PI phenotypes.
AuthorsL L Field, N Boyd, T J Bowen, J K Kelly, L R Sutherland
JournalThe American journal of gastroenterology (Am J Gastroenterol) Vol. 84 Issue 7 Pg. 753-5 (Jul 1989) ISSN: 0002-9270 [Print] United States
PMID2741885 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Genetic Markers
  • Immunoglobulin Allotypes
  • Immunoglobulin Gm Allotypes
  • Protease Inhibitors
Topics
  • Colitis, Ulcerative (genetics)
  • Crohn Disease (genetics)
  • Genetic Markers (blood)
  • Humans
  • Immunoglobulin Allotypes (genetics)
  • Immunoglobulin Gm Allotypes (genetics)
  • Phenotype
  • Protease Inhibitors (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: